NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.00% | -2.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.00% | -2.80% | |||
| Cost of Revenue | -33.11% | -2.85% | |||
| Gross Profit | -12.29% | -2.79% | |||
| SG&A Expenses | 7.24% | -10.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.54% | -5.34% | |||
| Operating Income | -215.11% | 32.04% | |||
| Income Before Tax | -145.11% | 21.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -145.11% | 21.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -145.11% | 21.94% | |||
| EBIT | -215.11% | 32.04% | |||
| EBITDA | -226.50% | 33.74% | |||
| EPS Basic | -142.84% | 22.56% | |||
| Normalized Basic EPS | -138.92% | 21.24% | |||
| EPS Diluted | -142.84% | 22.56% | |||
| Normalized Diluted EPS | -138.92% | 21.24% | |||
| Average Basic Shares Outstanding | 0.99% | 0.76% | |||
| Average Diluted Shares Outstanding | 0.99% | 0.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||